Autoplaque vs TeraRecon Cardiovascular.Calcification.CT

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cedars-Sinai Medical Center: AIM
VS

AI Verdict

Both Autoplaque and TeraRecon Cardiovascular.Calcification.CT are AI-powered tools designed for the analysis of coronary arteries from CT images. Autoplaque specializes in the quantitative analysis of atherosclerotic plaques and luminal stenoses to aid in risk prediction and treatment guidance. TeraRecon, while also offering vessel and stenosis analysis, explicitly focuses on the automatic detection and measurement of calcified plaques for calcium scoring systems.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a detailed, quantitative analysis of both coronary plaque characteristics and luminal stenoses from CT angiography images. This tool is ideal for clinicians focused on comprehensive atherosclerotic plaque characterization to inform heart attack risk prediction and guide treatment strategies, with the flexibility of a workstation-based application allowing for clinician review and editing.

View Autoplaque →

Choose TeraRecon Cardiovascular.Calcification.CT if…

Choose TeraRecon Cardiovascular.Calcification.CT if your workflow prioritizes automated and rapid coronary artery calcium scoring (Agatston, volume, mean mass) from CT images. This solution is particularly well-suited for practices seeking a comprehensive cardiac CT package that includes not only calcification analysis but also broader cardiac structure segmentation and functional analysis, often deployed as a SaaS for streamlined integration.

View TeraRecon Cardiovascular.Calcification.CT →

When choosing between Autoplaque and TeraRecon Cardiovascular.Calcification.CT, physicians should consider their primary analytical needs. Autoplaque, developed by Cedars-Sinai AIM, excels at comprehensive quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. Its key strength lies in detailed plaque characterization and stenosis measurement, offering automated vessel, plaque, and lumen segmentation that is reviewable and editable. This makes Autoplaque particularly well-suited for clinicians focused on in-depth atherosclerotic plaque analysis and precise stenosis assessment for heart attack risk prediction and treatment guidance.

In contrast, TeraRecon Cardiovascular.Calcification.CT specializes in the automatic detection and measurement of calcifications in coronary arteries, providing a mask for calcium scoring systems. While it also offers vessel segmentation and analysis, its core utility is in generating Agatston, volume, and mean mass measurements for calcium scoring. The key practical difference is Autoplaque’s broader focus on both plaque and stenosis quantification, whereas TeraRecon’s tool is more geared towards efficient and automated calcium scoring. Physicians prioritizing detailed plaque morphology and luminal narrowing analysis would likely find Autoplaque more aligned with their needs, while those primarily focused on streamlined and automated calcium scoring for risk stratification may prefer TeraRecon Cardiovascular.Calcification.CT.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque TeraRecon Cardiovascular.Calcification.CT
Pricing Not disclosed Subscription-based
Deployment Workstation-based software, runs on Windows or Mac computer platforms Containerized application (SaMD), also available as SaaS within Eureka Clinical AI platform.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque TeraRecon Cardiovascular.Calcification.CT
Name Autoplaque TeraRecon Cardiovascular.Calcification.CT
Company Cedars-Sinai Medical Center: AIM Terarecon
Description FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. AI-powered software as a medical device (SaMD) that analyzes CT images to automatically detect and measure calcifications in the coronary arteries, providing a mask for calcium scoring systems.
Key Features AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area Automatic 3D segmentation of calcified plaques in coronary arteries; Outputs mask for calcium scoring systems; Supports Agatston score, volume, mean mass (mg) measurements; Part of CT Cardiac package with zero-click centerline creation; Vessel segmentation and analysis (plaque, stenosis, curvature, tortuosity); Cardiac structure segmentation and functional analysis; Atrium & pulmonary vein analysis for EP planning; Pre-operative evaluation of coronary arteries

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and TeraRecon Cardiovascular.Calcification.CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses from CT angiography images. It offers analysis of calcified and non-calcified plaque volumes, stenosis percentage, and remodeling index. In contrast, TeraRecon Cardiovascular.Calcification.CT primarily focuses on automatic 3D segmentation of calcified plaques in coronary arteries and outputs a mask for calcium scoring systems, supporting Agatston score, volume, and mean mass measurements, while also including general vessel segmentation and analysis for plaque and stenosis.
Autoplaque provides AI-powered quantitative analysis for atherosclerotic plaque, including calcified and non-calcified plaque volume, stenosis percentage, remodeling index, plaque length measurement, and vessel diameter and area. TeraRecon Cardiovascular.Calcification.CT automatically detects and measures calcifications in coronary arteries, providing a mask for calcium scoring systems that support Agatston score, volume, and mean mass (mg) measurements, in addition to vessel segmentation and analysis for plaque and stenosis.
Autoplaque focuses on the analysis of coronary anatomy and pathology from CT angiographic images, including review in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views. TeraRecon Cardiovascular.Calcification.CT, as part of its CT Cardiac package, offers broader capabilities such as cardiac structure segmentation and functional analysis, atrium & pulmonary vein analysis for EP planning, and pre-operative evaluation of coronary arteries.
Autoplaque explicitly features automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician. The provided information for TeraRecon Cardiovascular.Calcification.CT does not explicitly state whether its automated segmentations are reviewable and editable by clinicians.
AI Tool Finder
AI-powered search. Results may not be comprehensive.